Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL.
Blood Adv. 2021 Nov 23;5(22):4771-4782. doi: 10.1182/bloodadvances.2021004777.
Blood Adv. 2021.
PMID: 34543384
Free PMC article.
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.
Isaksen KT, Beiske K, Smeland EB, Jørgensen J, Brodtkorb M, Myklebust JH, Jerkeman M, Meriranta L, Karjalainen-Lindsberg ML, Leppä S, Scott DW, Holte H, Blaker YN.
Isaksen KT, et al.
EJHaem. 2020 Dec 5;2(1):104-108. doi: 10.1002/jha2.109. eCollection 2021 Feb.
EJHaem. 2020.
PMID: 35846101
Free PMC article.
No abstract available.
Item in Clipboard
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.
Isaksen KT, Galleberg R, Mastroianni MA, Rinde M, Rusten LS, Barzenje D, Ramslien F, Fluge O, Slaaen M, Meyer P, Liestol K, Smeland EB, Lingjarde OC, Holte H, Brodtkorb M.
Isaksen KT, et al.
Haematologica. 2023 Sep 1;108(9):2454-2466. doi: 10.3324/haematol.2022.282289.
Haematologica. 2023.
PMID: 36861406
Free PMC article.
Item in Clipboard
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K, Myklebust JH.
Spasevska I, et al.
Blood Adv. 2023 Dec 12;7(23):7216-7230. doi: 10.1182/bloodadvances.2023010158.
Blood Adv. 2023.
PMID: 37695745
Free PMC article.
Item in Clipboard
Cite
Cite